{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T06:44:33Z","timestamp":1778136273589,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11-12","license":[{"start":{"date-parts":[[1997,11,1]],"date-time":"1997-11-01T00:00:00Z","timestamp":878342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1997,11]]},"DOI":"10.1007\/bf01294729","type":"journal-article","created":{"date-parts":[[2005,3,25]],"date-time":"2005-03-25T04:02:31Z","timestamp":1111723351000},"page":"1287-1293","source":"Crossref","is-referenced-by-count":26,"title":["Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson's disease"],"prefix":"10.1007","volume":"104","author":[{"given":"J. A.","family":"Molina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"de Bustos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. J.","family":"Jim\u00e9nez-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Benito-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ort\u00ed-Pareja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Gasallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tall\u00f3n-Barranco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Arenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Enr\u00edquez-de-Salamanca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"879","volume":"46","author":"RA Abbott","year":"1992","unstructured":"Abbott RA, Cox M, Markus H, Tomkins A (1992) Diet, body size and micronutrient status in Parkinson's disease. Eur J Clin Nutr 46: 879?884","journal-title":"Eur J Clin Nutr"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/0006-2952(90)90640-7","volume":"39","author":"JD Adams Jr","year":"1990","unstructured":"Adams JD Jr, Odunze IN, Sevanian A (1990) Induction by l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine of lipid peroxidation in vivo in vitamin E deficient mice. Biochem Pharmacol 39: R5-R8","journal-title":"Biochem Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/mds.870100507","volume":"10","author":"JE Ahlskog","year":"1995","unstructured":"Ahlskog JE, Uitti RJ, Low PA, Tyce GM, Nickander KK, Petersen RC, Kokmen E (1995) No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease. Mov Disord 10: 566?573","journal-title":"Mov Disord"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1353-8020(96)00047-8","volume":"3","author":"L Ayuso-Peralta","year":"1997","unstructured":"Ayuso-Peralta L, Jim\ufffdnez-Jim\ufffdnez FJ, Cabrera-Valdivia F, Molina JA, Rabasa M, Almazan J, Tabernero C, de Pedro-Cuesta J, Gim\ufffdnez-Rold\ufffdn S (1997) Premorbid dietetic habits and risk for Parkinson's disease. Parkinsonism Rel Disord 3: 55?61","journal-title":"Parkinsonism Rel Disord"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1212\/WNL.36.5.735","volume":"36","author":"RJ Baldessarini","year":"1986","unstructured":"Baldessarini RJ, Kula NS, Francouer D, Finklestein SP (1986) Antioxidants fail to inhibit depletion of striatal dopamine by MPTP. Neurology 36: 735","journal-title":"Neurology"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0006-8993(89)91530-8","volume":"476","author":"JL Cadet","year":"1989","unstructured":"Cadet JL, Katz M, Jackson-Lewis V, Fahn S (1989) Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence. Brain Res 476: 10?15","journal-title":"Brain Res"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.410320420","volume":"32","author":"DT Dexter","year":"1992","unstructured":"Dexter DT, Ward RH, Wells FR, Daniel SE, Lees AJ, Peters TJ, Jenner P, Marsden CD (1992) Alpha-tocopherol levels in brain are not altered in Parkinson's disease. Ann Neurol 32: 591?593","journal-title":"Ann Neurol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.410350309","volume":"35","author":"DT Dexter","year":"1994","unstructured":"Dexter DT, Brooks DJ, Harding AE, Burn DJ, Muller DP, Goss-Sampson MA, Jenner PG, Marsden CD (1994) Nigrostriatal function in vitamin E deficiency: clinical, experimental and positron emission tomographic studies. Ann Neurol 35: 298?303","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"CR9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/ajcn\/53.1.380S","volume":"53","author":"S Fahn","year":"1991","unstructured":"Fahn S (1991) An open trial of high-dosage antioxidants in early Parkinson's disease. Am J Clin Nutr 53 [Suppl 1]: 380?382","journal-title":"Am J Clin Nutr"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ana.410320616","volume":"32","author":"S Fahn","year":"1992","unstructured":"Fahn S, Cohen G (1992) The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 32: 804?812","journal-title":"Ann Neurol"},{"key":"CR11","unstructured":"Fahn S, Elton RL, and members of the UPDRS Development Committee (1987) Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden SD, Goldstein M, Calne DB (eds) Recent developments in Parkinson's disease, vol II. Florham Park, New Jersey, pp 153?163"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1212\/WNL.42.5.1064","volume":"42","author":"P Fern\ufffdndez-Calle","year":"1992","unstructured":"Fern\ufffdndez-Calle P, Molina JA, Jim\ufffdnez-Jim\ufffdnez FJ, V\ufffdzquez A, Pondai M, Garc\ufffda-Ruiz PJ, Urra DG, Domingo J, Codoceo R (1992) Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease. Neurology 42: 1064?1066","journal-title":"Neurology"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/archneur.1988.00520360068014","volume":"45","author":"LI Golbe","year":"1988","unstructured":"Golbe LI, Farrell TM, Davis PH (1988) Case-control study of early life dietary factors in Parkinson's disease. Arch Neurol 45: 1350?1353","journal-title":"Arch Neurol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/mds.870050116","volume":"5","author":"LI Golbe","year":"1990","unstructured":"Golbe LI, Farrell TM, Davis PH (1990) Follow-up study on early-life protective and risk factors in Parkinson's disease. Mov Disord 5: 66?70","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"CR15","first-page":"76","volume":"7","author":"LI Golbe","year":"1992","unstructured":"Golbe LI, Liu JC, Stern MB, Dranoff J (1992) Premorbid dietary factors in young-onset Parkinson's disease (YOPD). Mov Disord 7 [Suppl 1]: 76","journal-title":"Mov Disord"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17: 427?442","journal-title":"Neurology"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/WNL.42.6.1142","volume":"42","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Ben-Shlomo SE, Daniel SE, Lees AJ (1992) What features improve the accuracy of clinical diagnosis in Parkinson's disease? A clinicopathological study. Neurology 42: 1142?1146","journal-title":"Neurology"},{"key":"CR18","first-page":"S212","volume":"[Suppl 4]","author":"A Jim\ufffdnez-Escrig","year":"1993","unstructured":"Jim\ufffdnez-Escrig A, Mart\ufffdnez-Castrillo JC, Garc\ufffda-Segovia J, Orensanz L, Sanz-Anquela JM, Ribera-Casado JM (1993) Dietetic habits in Parkinson's disease. XVth World Congress of Neurology, Vancouver, Canada, September 1993. Can J Neurol Sci [Suppl 4]: S212","journal-title":"Can J Neurol Sci"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/pgmj.68.802.634","volume":"68","author":"D King","year":"1992","unstructured":"King D, Playfer JR, Roberts NB (1992) Concentrations of vitamins A, C, and E in elderly patients with Parkinson's disease. Postgrad Med J 68: 634?637","journal-title":"Postgrad Med J"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0304-3940(86)90602-6","volume":"69","author":"G Martinovits","year":"1986","unstructured":"Martinovits G, Melamed E, Cohen O, Rosenthal J, Uzzan A (1986) Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP). Neurosci Lett 69: 192?197","journal-title":"Neurosci Lett"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/WNL.46.5.1270","volume":"46","author":"DM Morens","year":"1996","unstructured":"Morens DM, Grandinetti A, Waslien CI, Park CB, Ross GW, White LR (1996) Casecontrol study of idiopathic Parkinson's disease and dietary vitamin E intake. Neurology 46: 1270?1274","journal-title":"Neurology"},{"key":"CR22","volume-title":"R-Sigma: Base de datos bioestadfstica para un ordenador personal","author":"E Moreu","year":"1990","unstructured":"Moreu E, Molinero LM, Fern\ufffdndez E (1990) R-Sigma: Base de datos bioestadfstica para un ordenador personal. Horus Hardware, Madrid"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0304-3940(90)90665-V","volume":"108","author":"IN Odunze","year":"1990","unstructured":"Odunze IN, Klaidman LK, Adams JD Jr (1990) MPTP toxicity in the mouse brain and vitamin E. Neurosci Lett 108: 346?349","journal-title":"Neurosci Lett"},{"key":"CR24","first-page":"S212","volume":"[Suppl 4]","author":"L Orensanz","year":"1993","unstructured":"Orensanz L, Jim\ufffdnez-Escrig A, Martinez-Castrillo JC, Garc\ufffda-Segovia J, Sanz-Anquela JM, Ribera-Casado JM (1993) Diet vitamins in Parkinson's disease. XVth World Congress of Neurology, Vancouver, Canada, September 1993. Can J Neurol Sci [Suppl 4]: S212","journal-title":"Can J Neurol Sci"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1212\/WNL.47.4.1037","volume":"47","author":"EJ Pappert","year":"1996","unstructured":"Pappert EJ, Tangney CC, Goetz CG, Ling ZD, Lipton JW, Stebbins GT, Carvey PM (1996) Alpha-tocopherol in the ventricular cerebropinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levies. Neurology 47: 1037?1042","journal-title":"Neurology"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3940(85)90229-0","volume":"60","author":"TL Perry","year":"1985","unstructured":"Perry TL, Yong RM, Clavier K, Jones K, Wright JM, Foulks JG, Wall RA (1985) Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse. Neurosci Lett 60: 109?114","journal-title":"Neurosci Lett"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0022-510X(87)90106-7","volume":"81","author":"TL Perry","year":"1987","unstructured":"Perry TL, Yong VW, Hansen S, Jones K, Bergeron C, Foulks JG, Wright JM (1987) ?-tocopherol and ?-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-l,2,3,6-tetrahydropyridine. J Neurol Sci 81: 321?331","journal-title":"J Neurol Sci"},{"key":"CR28","first-page":"182","volume":"24","author":"CM Tanner","year":"1988","unstructured":"Tanner CM, Cohen JA, Summerville BC, Goetz CG (1988) Vitamin use and Parkinson's disease. Ann Neurol 24: 182","journal-title":"Ann Neurol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1212\/WNL.39.5.660","volume":"39","author":"CM Tanner","year":"1989","unstructured":"Tanner CM, Chem B, Cohen JA, Wang W, Peng M, Summerville BC, Liu Z, Liang X, Kao LC, Goetz CG (1989) Dietary antioxidant vitamins and the risk of developing Parkinson's disease. Neurology 39 [Suppl]: 181","journal-title":"Neurology"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1056\/NEJM199301213280305","volume":"328","author":"The Parkinson Study Group","year":"1993","unstructured":"The Parkinson Study Group (1993) Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 328: 176?183","journal-title":"N Engl J Med"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0304-3940(94)11158-F","volume":"184","author":"H Tohgi","year":"1995","unstructured":"Tohgi H, Abe T, Saheki M, Hamato F, Sasaki K, Takahashi S (1995) Reduced and oxidized forms of glutathione and ?-tocopherol in the cerebrospinal fluid of parkinsonian patients: comparison between before and after L-dopa treatment. Neurosci Lett 184: 21?24","journal-title":"Neurosci Lett"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ajcn\/53.1.95","volume":"53","author":"GT Vatassery","year":"1991","unstructured":"Vatassery GT, Nelson MJ, Maletta GJ, Kuskowski MA (1991) Vitamin E (tocopherols) in human cerebrospinal fluid. Am J Clin Nutr 53: 95?99","journal-title":"Am J Clin Nutr"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1017\/S0317167100042219","volume":"19","author":"P Vieregge","year":"1992","unstructured":"Vieregge P, Maravic CV, Friedrich HJ (1992) Life-style and dietary factors early and late in Parkinson's disease. Can J Neurol Sci 19: 170?173","journal-title":"Can J Neurol Sci"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0304-3940(86)90012-1","volume":"63","author":"WW Yong","year":"1986","unstructured":"Yong WW, Perry TL, Krisman AA (1986) Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-l,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment. Neurosci Lett 63: 56?60","journal-title":"Neurosci Lett"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01294729.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01294729\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01294729","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T13:49:18Z","timestamp":1586180958000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01294729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":34,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["BF01294729"],"URL":"https:\/\/doi.org\/10.1007\/bf01294729","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,11]]}}}